In brief
The recent decision to scale back foreign aid signals a major change in U.S. global health policy, impacting millions globally.
The Trump administration has announced a sweeping decision to halt U.S. financial support for Gavi, the organization that has played a vital role in providing vaccines to children in developing countries for the past 25 years, saving millions of lives. Additionally, funding for malaria prevention efforts, which combat one of the world's deadliest diseases, will also see significant cuts.While the administration plans to reduce aid drastically, it will continue to fund some vital programs, including grants for H.I.V. and tuberculosis treatments, as well as food assistance for countries in conflict and experiencing natural disasters. This new strategy is outlined in a lengthy spreadsheet sent to Congress by the United States Agency for International Development (U.S.A.I.D.), which lists ongoing and terminated foreign aid projects.Despite a commitment to continue 898 U.S.A.I.D. awards, the cuts result in the termination of 5,341 programs, representing a fundamental shift in U.S. foreign aid policy, which has historically positioned the country as a supporter to developing nations. The expected reduction in annual spending from U.S.A.I.D. is drastic, down from $40 billion to an unobligated budget of $8.3 billion, raising concerns about the future of global health initiatives.
